OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Lightspeed is in discussions to lead the funding round, sources say.

The biggest bombshells from Apple's trade secrets lawsuit against OpenAI

In a filing, Apple says former employees working for OpenAI retained access to the iPhone maker's systems after leaving.

Sam Altman Is Waiting for a $1 Trillion OpenAI Valuation. SoftBank Has a $40 Billion Loan Due March 2027.

OpenAI recently filed paperwork for its IPO, but advisors were not convinced that the company could (or should) fetch the ...

The wildest allegations in Apple’s trade secrets lawsuit against OpenAI

Apple’s trade secrets lawsuit against OpenAI contains allegations that range from employees joking about unauthorized access ...

The leaders responsible for keeping OpenAI's AI safe keep leaving

OpenAI just lost another leader of one of its safety teams. The company's safety and alignment teams have had high turnover ...

Developers Claim OpenAI’s New AI Model is Going Rogue and Deleting Files

There’s been a big push among AI developers in recent years towards the development of more “agentic” systems—that is, ...

OpenAI’s growing challenges narrow its IPO window

Plus, Apple’s legal sparring, and Wall Street’s problem with AI drug discovery.

We Now Know What OpenAI’s First Gadget Might Look Like. It’s a Direct Challenge to Apple and Amazon

OpenAI’s first consumer device will reportedly be a portable, screenless smart speaker with cameras, environmental sensors, ...